SemisolidIVRTQualityChecker

Semisolid IVRT Quality Checker — In Vitro Release Testing for Semisolid Dosage Forms

ℹ️  Utility assesses the release kinetics of drug substances from ointments, creams, and gels according to USP <1724>:
     • Release Rate (must match reference product, typically 90-110%)
     • Method Precision (RSD ≤ 10% for a series of 6 cells)
     • Linearity of Higuchi plot (R² ≥ 0.98)
     • Lag Time (≤ 30 min)
     • Membrane Integrity (Critical System Suitability Parameter)

⚠️  CRITICAL: Membrane integrity failure completely invalidates test results!
     Non-linearity of the release plot indicates instability of the product structure or diffusion issues.

Usage:
  SemisolidIVRTQualityChecker.exe                            → demo mode (console output)
  SemisolidIVRTQualityChecker.exe input.csv output.json      → evaluate your data

Input format:
BatchNumber,ProductName,ReleaseRateMcgPerCm2PerHr,RSD_Percent,LagTimeMinutes,CorrelationCoefficientR2,TotalReleasedPercent,MembraneIntegrityCheck

Example (Membrane: 1.0=Pass, 0.0=Fail):
  CREAM-2026-IVRT-001,Diclofenac Gel 1%,45.2,4.5,12.0,0.995,45.0,1.0

— WHY IS THIS NEEDED?
In Vitro Release Testing (IVRT) is a key quality control method for semisolid dosage forms (ointments, creams, gels).
It demonstrates bioequivalence of the product and stability of its manufacturing process.
According to FDA and USP guidelines, IVRT is used to confirm that changes in composition or process do not affect the availability of the active ingredient.

⚠️  CRITICAL:
• Release Rate — main criterion for comparison with reference product (Q1/Q2/Q3 sameness).
• RSD ≤ 10% — ensures reproducibility of the method between Franz cell units.
• Linearity (R² ≥ 0.98) — confirms that the process is diffusion-controlled (Higuchi kinetics).
• Membrane Integrity — if the membrane is damaged, data is invalid.
• Sink Conditions — 20-80% of the drug should be released for correct kinetic calculation.

Key features:
• Assessment of Higuchi kinetic parameters
• System Suitability Testing (SST) control via membrane integrity and linearity
• Precision check (RSD)
• Generation of reports for regulatory dossiers and LIMS LabWare
• Support for USP <1724> and FDA Guidance for Topical Dermatological Products requirements

Critical parameters:
• Release Rate: 90-110% of reference (or specified range)
• RSD: ≤ 10.0%
• Lag Time: ≤ 30 min
• Coefficient of Determination (R²): ≥ 0.98
• Total Release: 20-80%
• Membrane Integrity: Pass

💡 Usage tips:
1. Apparatus: Use vertical or horizontal Franz cells with controlled temperature (32±1°C for skin).
2. Membrane: Use synthetic membranes (e.g., PVDF or cellulose) inert to the product.
3. Degassing: Receptor solution must be degassed to prevent bubble formation under the membrane.
4. Sampling: Automated sampling is preferred to minimize errors and maintain volume.
5. Statistics: For new drug registration, comparison with a reference sample is required (f2 factor or confidence intervals).

⚠️ Note: IVRT does not measure skin penetration (which is done by IVPT), but it correlates with it and is the standard for quality control of semisolid manufacturing.